Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1050+0.0050 (+5.00%)
At close: 10:22AM EST
Full screen
Loading interactive chart...
  • GlobeNewswire

    Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel

    Salud Pharma to launch product in Colombia, Panama, and Costa RicaWINNIPEG, Manitoba, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has recently signed a distribution agreement with Salud Pharma S.A. (“Salud Pharma”) for its coactiv+™ Antimicrobial Hydrogel wound care and DermaKB™ scalp care products. Once Kane obtains 510(k) approval from the FDA, Salud Pharma through its distribution partners will register

  • GlobeNewswire

    Kane Biotech Announces Loan Transaction

    WINNIPEG, Manitoba, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has reached an agreement to obtain loans (the “Loans”) in the aggregate amount of $2,000,000 from two lenders (the “Lenders”). The Loans will bear interest at 12% per annum and mature on March 31, 2024. As partial consideration for providing the Loans, the Lenders will be issued an aggregate of 4,705,882 common shares of the Company (the “Bon

  • GlobeNewswire

    Kane Biotech Announces Third Quarter 2022 Financial Results

    Company Files First 510(k) Application in Wound CareWINNIPEG, Manitoba, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2022 financial results. Financial Highlights: Total revenue for the three months ended September 30, 2022 was $571,686 an increase of 5% compared to $541,302 in the three months ended September 30, 2021. In the nine months ended September 30, 2022, total revenue increased by 65% to